Sanofi India Limited

Company Profile

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

1,097

Website

www.sanofi.com/en/india/investors

Country

India

Exchange

BSE

Mumbai, IndiaSubsidiary of Hoechst GmbH

Sanofi India manufactures and trades in drugs and pharmaceutical products in India, Singapore and globally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors.

It also exports its products. Incorporated in 1956 and headquartered in Mumbai, India, the company was formerly known as Aventis Pharma Limited before rebranding in May 2012. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.

Key Stats

52-Week Range

₹3057.60₹5922.45

Beta0.16

Trailing P/E25.01

Forward P/E18.46

Trailing EPS134.43

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS Estimate39.30

Target Mean Price₹4935.67

RecommendationBuy

Recommendation Mean2.00

Recent SEC Filings

SEC filings for this ticker are not available yet.